Carfilzomib-d8
Modify Date: 2024-01-09 11:55:52
Carfilzomib-d8 structure
|
Common Name | Carfilzomib-d8 | ||
|---|---|---|---|---|
| CAS Number | 1537187-53-3 | Molecular Weight | 727.96 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 975.6±65.0 °C at 760 mmHg | |
| Molecular Formula | C40H49D8N5O7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 543.8±34.3 °C | |
Use of Carfilzomib-d8Carfilzomib-d8 is deuterium labeled Carfilzomib. Carfilzomib (PR-171) is an irreversible proteasome inhibitor with an IC50 of 5 nM in ANBL-6 and RPMI 8226 cells. |
| Name | N-[(2S)-2-{[(2H8)-4-Morpholinylacetyl]amino}-4-phenylbutanoyl]-L-leucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyl-2-oxiranyl]-1-oxo-2-pentanyl}-L-phenylalaninamide |
|---|---|
| Synonym | More Synonyms |
| Description | Carfilzomib-d8 is deuterium labeled Carfilzomib. Carfilzomib (PR-171) is an irreversible proteasome inhibitor with an IC50 of 5 nM in ANBL-6 and RPMI 8226 cells. |
|---|---|
| Related Catalog | |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 975.6±65.0 °C at 760 mmHg |
| Molecular Formula | C40H49D8N5O7 |
| Molecular Weight | 727.96 |
| Flash Point | 543.8±34.3 °C |
| Exact Mass | 727.476013 |
| LogP | 6.71 |
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
| Index of Refraction | 1.551 |
| N-[(2S)-2-{[(2H8)-4-Morpholinylacetyl]amino}-4-phenylbutanoyl]-L-leucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyl-2-oxiranyl]-1-oxo-2-pentanyl}-L-phenylalaninamide |
| L-Phenylalaninamide, N-[(2S)-2-[[2-(4-morpholinyl-d8)acetyl]amino]-1-oxo-4-phenylbutyl]-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]- |